SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001516551-22-000010
Filing Date
2022-05-12
Accepted
2022-05-12 09:08:42
Documents
17
Period of Report
2022-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K skye-20220511.htm   iXBRL 8-K 71718
2 EX-2.1 a21_projectfran-arrangemen.htm EX-2.1 1042671
3 EX-10.1 exhibit101.htm EX-10.1 75863
4 EX-10.2 exhibit102.htm EX-10.2 78133
5 EX-99.1 skye_051222xpoapressrelease.htm EX-99.1 34276
9 GRAPHIC image_0.jpg GRAPHIC 186
  Complete submission text file 0001516551-22-000010.txt   1650591

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20220511.xsd EX-101.SCH 1921
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20220511_lab.xml EX-101.LAB 22080
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20220511_pre.xml EX-101.PRE 11526
11 EXTRACTED XBRL INSTANCE DOCUMENT skye-20220511_htm.xml XML 10674
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 22915970
SIC: 2834 Pharmaceutical Preparations